Ainos (STU:FZX0) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:FZX0 Ainos Inc STU:FZX0
22 GF Score
Price €12.50
GF Value €0.92
! 9 Warning Signs
View Full Analysis

What is Ainos Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

STU:FZX0
22GF Score
Ainos Inc STU:FZX0
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ainos (STU:FZX0) Overvalued in 2026?

Based on GuruFocus' analysis, Ainos stock appears to be overvalued. The current stock price of €12.50 is trading 1258.7% above its estimated GF Value™ of €0.92.

Key valuation signals for STU:FZX0:

  • Interest Received:
  • GF Value™: €0.92 vs. price of €12.50 (1258.7% above fair value)
  • GF Score™: 22/100 with 9 warning signs

No single metric tells the full story. See the STU:FZX0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ainos Business Description

Other Exchanges AIMD:USA
Address 3050 Post Oak Boulevard, Suite 510-T80, Houston, TX, USA, 77056
Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.
22GF Score

Get the complete analysis for STU:FZX0

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.50
Price
€0.92
GF Value